Iloperidone Tablet
Product Images NDC 0378-0634

11 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Iloperidone (NDC 0378-0634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

9e1900e4-eae1-4295-826c-d598e3486e5a-01 (B8537f38 Db2d 4c90 A198 975a06647818 01)

9e1900e4-eae1-4295-826c-d598e3486e5a-01 (B8537f38 Db2d 4c90 A198 975a06647818 01)
Chemical structure of iloperidone, showing its molecular arrangement of atoms and bonds typically used in pharmaceutical characterization.*
FDA Label Image

Image (4af04a27 Fb62 4270 A591 51a1ca63d714 135 1)

Image (4af04a27 Fb62 4270 A591 51a1ca63d714 135 1)
A scatter plot showing fold change and 90% confidence intervals for iloperidone and other compounds as CYP2D6 and CYP3A4 inhibitors. The x-axis represents change relative to reference (ratio) from 0.0 to 3.0. Data points are shown for Cmax and AUC∞ values of fluoxetine, iloperidone, P88, and P95 under different inhibitor conditions.*
FDA Label Image

Image (B8537f38 Db2d 4c90 A198 975a06647818 175 1)

Image (B8537f38 Db2d 4c90 A198 975a06647818 175 1)
A Kaplan-Meier survival curve chart showing the proportion of subjects with relapse or impending relapse over 182 days after randomization. The chart compares two groups: 'Ilo' (iloperidone) shown with a solid blue line and 'Pbo' (placebo) shown with a dashed red line. The x-axis represents days from randomization, and the y-axis represents the proportion of relapse. The number of subjects at risk is listed below the x-axis for each group at different time points.*
FDA Label Image

Image (4af04a27 Fb62 4270 A591 51a1ca63d714 146 1)

FDA Label Image

9e1900e4-eae1-4295-826c-d598e3486e5a-02 (B8537f38 Db2d 4c90 A198 975a06647818 02)

9e1900e4-eae1-4295-826c-d598e3486e5a-02 (B8537f38 Db2d 4c90 A198 975a06647818 02)
Packaging label for Iloperidone 1 mg oral tablets by Mylan Pharmaceuticals Inc. The label indicates 60 tablets per container, with storage instructions to keep at 25°C (77°F) with permitted excursion to 15°-30°C, and protection from light and moisture. The label also shows the NDC 0378-0630-91 and includes manufacturer details and a barcode.*
FDA Label Image

9e1900e4-eae1-4295-826c-d598e3486e5a-03 (B8537f38 Db2d 4c90 A198 975a06647818 03)

9e1900e4-eae1-4295-826c-d598e3486e5a-03 (B8537f38 Db2d 4c90 A198 975a06647818 03)
The label for Iloperidone 2 mg tablets by Mylan Pharmaceuticals Inc. features a white background with green and black text. It indicates the product name, dosage strength, quantity of 60 tablets, and storage instructions. The label includes manufacturer and bar code details, a circular tablet imprint reading '051', and storage temperature guidance from 15° to 30°C (59° to 86°F).*
FDA Label Image

9e1900e4-eae1-4295-826c-d598e3486e5a-04 (B8537f38 Db2d 4c90 A198 975a06647818 04)

9e1900e4-eae1-4295-826c-d598e3486e5a-04 (B8537f38 Db2d 4c90 A198 975a06647818 04)
Label for Iloperidone 4 mg tablets by Mylan Pharmaceuticals Inc. The label includes storage instructions, dosage form as tablets, count of 60 tablets, and a barcode. It shows the NDC number 0378-0632-91 and has manufacturer details including Mylan Pharmaceuticals Inc. and Inventia Healthcare Private Limited.*
FDA Label Image

9e1900e4-eae1-4295-826c-d598e3486e5a-05 (B8537f38 Db2d 4c90 A198 975a06647818 05)

9e1900e4-eae1-4295-826c-d598e3486e5a-05 (B8537f38 Db2d 4c90 A198 975a06647818 05)
Packaging label for Iloperidone 6 mg tablets, an oral prescription drug by Mylan Pharmaceuticals Inc. The label shows the tablet imprint "053", storage instructions, and a count of 60 tablets. It includes manufacturer and distributor details, barcode, and NDC 0378-0633-91.*
FDA Label Image

9e1900e4-eae1-4295-826c-d598e3486e5a-06 (B8537f38 Db2d 4c90 A198 975a06647818 06)

9e1900e4-eae1-4295-826c-d598e3486e5a-06 (B8537f38 Db2d 4c90 A198 975a06647818 06)
Label for Iloperidone tablets 8 mg, manufactured by Mylan Pharmaceuticals Inc. The label includes storage instructions to keep the product at 25°C with allowed excursions, warnings to protect from light and moisture, and a note to keep out of reach of children. It specifies the package contains 60 tablets and features a barcode along with manufacturing and labeler addresses.*
FDA Label Image

9e1900e4-eae1-4295-826c-d598e3486e5a-07 (B8537f38 Db2d 4c90 A198 975a06647818 07)

9e1900e4-eae1-4295-826c-d598e3486e5a-07 (B8537f38 Db2d 4c90 A198 975a06647818 07)
Packaging label for Iloperidone 10 mg oral tablets, containing 60 tablets. The label shows the drug name Iloperidone in green and black text, dosage strength (10 mg) in a green box, and a sample image of a white tablet marked with '055'. It includes storage instructions, manufacturer details (Mylan Pharmaceuticals Inc., Morgantown, WV, and Inventia Healthcare Private Limited, India), a barcode, and is marked Rx only.*
FDA Label Image

9e1900e4-eae1-4295-826c-d598e3486e5a-08 (B8537f38 Db2d 4c90 A198 975a06647818 08)

9e1900e4-eae1-4295-826c-d598e3486e5a-08 (B8537f38 Db2d 4c90 A198 975a06647818 08)
Iloperidone 12 mg tablets packaging label by Mylan Pharmaceuticals Inc. The label shows the drug name, strength (12 mg), and dosage form (tablets). It indicates a quantity of 60 tablets and includes storage instructions, manufacturer details, and a barcode. The label states 'Rx only' and provides handling precautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.